Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Find trials by sponsor or company

Search by sponsors

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results for “Sanofi”

Efficacy and Safety of Lixisenatide Versus Placebo on Top of Basal Insulin and/or Oral Antidiabetic Treatment in Older Type 2 Diabetic PatientsCompleted
NCT01798706Phase 3Updated Apr 18, 2017
Sponsor: Sanofi
Type 2 Diabetes
United States, Australia, Bulgaria, Canada, Denmark +8 more
Characteristics of Glargine in Type 2 DiabeticsCompleted
NCT00574912Phase 1Updated Apr 17, 2017
Sponsor: Vanderbilt University Medical Center
Type 2 Diabetes
United States
Cabazitaxel at 20 mg/m² Compared to 25 mg/m² With Prednisone for the Treatment of Metastatic Castration Resistant Prostate CancerCompleted
NCT01308580Phase 3Updated Apr 17, 2017
Sponsor: Sanofi
Prostate Cancer
United States, Argentina, Australia, Belgium, Brazil +17 more
An Open Label Trial for Treating Carpometacarpal Osteoarthritis of the Thumb: Pilot StudyCompleted
NCT00198029NAUpdated Apr 17, 2017
Sponsor: Hospital for Special Surgery, New York
Carpometacarpal Osteoarthritis
United States
Comparison of Alemtuzumab and Rebif® Efficacy in Multiple Sclerosis, Study TwoCompleted
NCT00548405Phase 3Updated Apr 17, 2017
Sponsor: Genzyme, a Sanofi Company
Multiple Sclerosis, Relapsing-Remitting
United States, Argentina, Australia, Austria, Belgium +18 more
A Study of Oxaliplatin and Capecitabine in Unresectable Metastatic Hepatocellular CancerTerminated
NCT03026803Phase 2Updated Apr 13, 2017
Sponsor: City of Hope Medical Center
Liver Cancer · Hepatocellular Cancer
United States
Reacquisition of Radioactive Iodine (RAI) Uptake of RAI-Refractory Metastatic Thyroid Cancers by Pretreatment With the Selective MEK Inhibitor AZD6244Completed
NCT00970359NAUpdated Apr 12, 2017
Sponsor: Memorial Sloan Kettering Cancer Center
Thyroid Cancer
United States
Capecitabine and Oxaliplatin in Patients With Advanced or Metastatic Pancreatic AdenocarcinomaCompleted
NCT00585078Phase 2Updated Apr 10, 2017
Sponsor: Beth Israel Deaconess Medical Center
Pancreatic Cancer
United States
Safety Study of Sargramostim in Treating Patients With Mild Cognitive Impairment Due to Alzheimer's DiseaseWithdrawn
NCT02667496Phase 2Updated Apr 7, 2017
Sponsor: Sanofi
Dementia Alzheimer's Type
United States
Human African Trypanosomiasis: First in Man Clinical Trial of a New Medicinal Product, the FexinidazoleCompleted
NCT00982904Phase 1Updated Apr 6, 2017
Sponsor: Drugs for Neglected Diseases
Human African Trypanosomiasis
France
Glargine Dosing in Hospitalized Patients With Type 2 Diabetes and Renal InsufficiencyCompleted
NCT00911625Phase 4Updated Apr 6, 2017
Sponsor: Loyola University
Type 2 Diabetes · Renal Insufficiency
United States
Fexinidazole (1200mg) Bioavailability Under Different Food Intake ConditionsCompleted
NCT01340157Phase 1Updated Mar 31, 2017
Sponsor: Drugs for Neglected Diseases
PK in Healthy Volunteers
France
Treatment of Older Adults With Acute Lymphoblastic LeukemiaCompleted
NCT00973752Phase 2Updated Mar 30, 2017
Sponsor: Massachusetts General Hospital
Acute Lymphoblastic Leukemia
United States
Granulocyte-colony Stimulating Factor (G-CSF) and Plerixafor Plus Sorafenib for Acute Myelogenous Leukemia (AML) With FLT3 MutationsCompleted
NCT00943943Phase 1Updated Mar 29, 2017
Sponsor: M.D. Anderson Cancer Center
Acute Myelogenous Leukemia · Leukemia
United States
The Endocrine Secretome After Gastric Bypass SurgeryCompleted
NCT03093298NAUpdated Mar 28, 2017
Sponsor: Filip Krag Knop
Obesity, Morbid · Type2 Diabetes
Pemetrexed &Oxaliplatin in Patients w Recurrent NSCLCa After Failure to Platinum Based Adjuvant ChemTerminated
NCT00612677Phase 2Updated Mar 23, 2017
Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Lung Cancer
United States
Two Regimens of SAR240550/Weekly Paclitaxel and Paclitaxel Alone as Neoadjuvant Therapy in Triple Negative Breast Cancer PatientsCompleted
NCT01204125Phase 2Updated Mar 22, 2017
Sponsor: Sanofi
Breast Cancer Female
France, Germany, Spain
Study to Evaluate the Efficacy and Safety of an Every Four Weeks Treatment Regimen of Alirocumab (REGN727/ SAR236553) in Patients With Primary Hypercholesterolemia (ODYSSEY CHOICE 1)Completed
NCT01926782Phase 3Updated Mar 21, 2017
Sponsor: Regeneron Pharmaceuticals
Hypercholesterolemia
United States, Bulgaria, Canada, Hungary, Israel +3 more
Controlled Comparison of Two Moxifloxacin Containing Treatment Shortening Regimens in Pulmonary TuberculosisCompleted
NCT00864383Phase 3Updated Mar 21, 2017
Sponsor: Global Alliance for TB Drug Development
Pulmonary Tuberculosis
China, India, Kenya, Malaysia, Mexico +4 more
Search for Serum/Plasma Biomarkers in Pompe's DiseaseUnknown
NCT03045042N/AUpdated Mar 20, 2017
Sponsor: Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Late Onset Pompe Disease · Pompe Disease
Spain
A Study of Aflibercept in Combination With FOLFIRI in Patients With Second-Line Metastatic Colorectal Cancer in JapanCompleted
NCT01882868Phase 2Updated Mar 14, 2017
Sponsor: Sanofi
Colorectal Cancer Metastatic
Japan
Phase III Study With Teriflunomide Versus Placebo in Patients With First Clinical Symptom of Multiple SclerosisCompleted
NCT00622700Phase 3Updated Mar 13, 2017
Sponsor: Sanofi
Multiple Sclerosis
United States, Australia, Austria, Bulgaria, Canada +16 more
A Study of the Effects of Renal Impairment on the Pharmacokinetics and Tolerability of Eliglustat TartrateCompleted
NCT02536937Phase 1Updated Mar 8, 2017
Sponsor: Sanofi
Gaucher Disease
United States
Trial of MEK Inhibitor and PI3K/mTOR Inhibitor in Subjects With Locally Advanced or Metastatic Solid TumorsCompleted
NCT01390818Phase 1Updated Mar 7, 2017
Sponsor: EMD Serono
Locally Advanced Solid Tumor · Metastatic Solid Tumor · Breast Cancer · Non Small Cell Lung Cancer
United States, Italy, Spain
A Study of Eliglustat Tartrate (Genz-112638) in Patients With Gaucher Disease (ENGAGE)Completed
NCT00891202Phase 3Updated Mar 3, 2017
Sponsor: Genzyme, a Sanofi Company
Gaucher Disease, Type 1
United States, Bulgaria, Canada, Colombia, India +7 more

Previous page Next page